CN112314819A - 一种改善睡眠的植物饮料及其制备方法 - Google Patents
一种改善睡眠的植物饮料及其制备方法 Download PDFInfo
- Publication number
- CN112314819A CN112314819A CN202011190446.7A CN202011190446A CN112314819A CN 112314819 A CN112314819 A CN 112314819A CN 202011190446 A CN202011190446 A CN 202011190446A CN 112314819 A CN112314819 A CN 112314819A
- Authority
- CN
- China
- Prior art keywords
- parts
- plant beverage
- improving sleep
- lily
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 241000196324 Embryophyta Species 0.000 claims abstract description 52
- 241000756137 Hemerocallis Species 0.000 claims abstract description 33
- 241000209140 Triticum Species 0.000 claims abstract description 22
- 235000021307 Triticum Nutrition 0.000 claims abstract description 22
- 241000234435 Lilium Species 0.000 claims abstract description 20
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 20
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 20
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 20
- 241000222336 Ganoderma Species 0.000 claims abstract description 19
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 18
- 235000021279 black bean Nutrition 0.000 claims abstract description 18
- 241001080798 Polygala tenuifolia Species 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 235000003599 food sweetener Nutrition 0.000 claims description 11
- 239000003765 sweetening agent Substances 0.000 claims description 11
- 239000008213 purified water Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 235000013599 spices Nutrition 0.000 claims description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
- 239000004378 Glycyrrhizin Substances 0.000 claims description 4
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 4
- 240000007926 Ocimum gratissimum Species 0.000 claims description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- 229940083980 lavender extract Drugs 0.000 claims description 4
- 235000020723 lavender extract Nutrition 0.000 claims description 4
- 235000011090 malic acid Nutrition 0.000 claims description 4
- 239000001630 malic acid Substances 0.000 claims description 4
- 229930189775 mogroside Natural products 0.000 claims description 4
- 229940092258 rosemary extract Drugs 0.000 claims description 4
- 235000020748 rosemary extract Nutrition 0.000 claims description 4
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- 229940013618 stevioside Drugs 0.000 claims description 4
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 4
- 235000019202 steviosides Nutrition 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 30
- 239000003814 drug Substances 0.000 abstract description 28
- 229940079593 drug Drugs 0.000 abstract description 19
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 16
- 206010022437 insomnia Diseases 0.000 abstract description 15
- 210000002216 heart Anatomy 0.000 abstract description 13
- 210000005036 nerve Anatomy 0.000 abstract description 6
- 241000208966 Polygala Species 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 239000002671 adjuvant Substances 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 230000000717 retained effect Effects 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract description 2
- 230000036407 pain Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 26
- 241000699670 Mus sp. Species 0.000 description 19
- 230000004622 sleep time Effects 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 230000001914 calming effect Effects 0.000 description 6
- 230000004620 sleep latency Effects 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 229960000796 barbital sodium Drugs 0.000 description 5
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000028527 righting reflex Effects 0.000 description 5
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 230000000517 effect on sleep Effects 0.000 description 4
- 230000000147 hypnotic effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 4
- 229960002275 pentobarbital sodium Drugs 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 229940125717 barbiturate Drugs 0.000 description 3
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229960001412 pentobarbital Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- MHQHHBYRYFICDV-UHFFFAOYSA-M sodium;pyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].O=C1CC(=O)[N-]C(=O)N1 MHQHHBYRYFICDV-UHFFFAOYSA-M 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000234280 Liliaceae Species 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010027304 Menopausal symptoms Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000010340 Sleep Deprivation Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- VGGSULWDCMWZPO-ODEMIOGVSA-N spinosin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=2C(=O)C=C(OC=2C=C1OC)C=1C=CC(O)=CC=1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VGGSULWDCMWZPO-ODEMIOGVSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241001636762 Polygala sibirica Species 0.000 description 1
- 241000208977 Polygalaceae Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- VGGSULWDCMWZPO-UHFFFAOYSA-N flavoayamenin Natural products COC1=CC=2OC(C=3C=CC(O)=CC=3)=CC(=O)C=2C(O)=C1C1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O VGGSULWDCMWZPO-UHFFFAOYSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
本发明公开了一种改善睡眠的植物饮料及其制备方法,属于食品领域,具体涉及饮料制备技术领域,以解决失眠会给患者带来极大的痛苦和心理负担的缺陷,按重量份数计,所述植物饮料包括以下组分:黄花菜10‑18份,酸枣仁5‑12份,远志3‑10份,莲子6‑12份,百合6‑12份,黑豆3‑6份,浮小麦10‑15份,灵芝6‑12份,辅料0.45‑2.25份,黄花菜具有良好的改善睡眠的功效,为君药;酸枣仁、远志安神益智,帮助改善睡眠,为臣药;莲子、百合、黑豆养阴益精,为佐药;浮小麦、灵芝载药上行以使药力缓留于上部心经,为使药。
Description
技术领域
一种改善睡眠的植物饮料及其制备方法,本发明属于食品领域,具体涉及饮料制备技术领域。
背景技术
植物饮料是以植物或植物提取物(茶,咖啡除外)为原料(非果蔬类植物的根,茎,叶,花,种子及竹或树木自身分泌的汁液,如谷物,食用菌,食用藻类和蕨类,可可,菊花等)经加工或发酵制成的饮料制品。
睡眠作为生命所必须的过程,是机体复原,整合和巩固记忆的重要环节,是健康不可缺少的组成部分。失眠是指无法入睡或无法保持睡眠状态,导致睡眠不足。又称入睡和维持睡眠障碍,为各种原因引起入睡困难,睡眠深度或频度过短,早醒及睡眠时间不足或质量差等,是一种常见病。失眠症是一种睡眠障碍,人群中的发生率越来越高。然而,很多人还没有正确认识失眠症的危害,认为其危害微乎其微,不用治疗。其实,这是对失眠症认识的一大误区。不同类型的失眠症,其危害程度不一样,即使是同一患者不同时间段其危害也会有所差异,失眠早期如不及时采取有效措施,可能会加重病情。
申请号CN201510103967.7公开了一种改善睡眠的饮料,其各原料组分的重量配比为:灯心草10-15份,鲜竹叶10-15份,落花生叶25-40份,五味子15-20份,浮小麦10-15份,合欢皮10-15份,茯神15-20份,红枣15-20份,酸枣仁15-20份,甘草8-20份,冰糖10-20份和蜂蜜20-30份。该发明的饮料选用多种上等原料精制而成,气味芳香宜人,色泽鲜艳亮丽;具有很好的养生和改善睡眠功效;其制备方法简单,适合规模化生产。
上述专利并没有具体的试验证据来证明其具有改善睡眠的功效,此外各组分之间如何配伍的不得而知。
发明内容
本发明的目的在于:提供一种改善睡眠的植物饮料及其制备方法,以解决失眠会给患者带来极大的痛苦和心理负担的缺陷。
本发明采用的技术方案如下:
一种改善睡眠的植物饮料,按重量份数计,所述植物饮料包括以下组分:黄花菜10-18份,酸枣仁5-12份,远志3-10份,莲子6-12份,百合6-12份,黑豆3-6份,浮小麦10-15份,灵芝6-12份,辅料0.45-2.25份。
本申请的技术方案中:
黄花菜又名安神菜,为百合科多年生草本植物,所以它不仅是厨中佳肴,也具有良好的食疗价值,具有镇定神经的功效,还有较显着的健脑、抗衰老功能,并能显着降低血清胆固醇的含量,所以对于体弱的脑力劳动者及高血压患者有很好的保健作用,黄花菜性甘,平,具有养血平肝,利尿消肿的功效,能治头晕,耳鸣,心悸,腰痛,吐血,衄血,大肠下血,水肿,淋病,咽痛,乳痈;
酸枣仁是鼠李科植物酸枣的干燥成熟种子,具有养心补肝,宁心安神,敛汗,生津的功效,用于虚烦不眠,惊悸多梦,体虚多汗,津伤口渴,酸枣仁含有芹菜素、葛根素、斯皮诺素及阿魏酸、酸枣黄素等成分,是养心安神药,主要功效:一是养心安神助眠,治疗由于心血不足,血不养心,或虚火上扰心神所致的虚烦失眠,及心悸不安,如著名经方酸枣仁汤,即是以酸枣仁为主药,配合知母、川芎、茯苓等组成,二是益阴敛汗,治疗因心气不足,不能敛汗所形成的虚汗汗多;
远志为远志科植物远志或卵叶远志的干燥根,苦、辛、温,归心、肾、肺经,安神益智,祛痰,消肿,用于心肾不交引起的失眠多梦,健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛等;
莲子为睡莲科植物莲的干燥成熟种子,莲子药性平和,味道甘、涩,归脾、肾、心经,莲子营养丰富,化学成分包括水溶性多糖、黄酮、脂肪酸、矿物质、蛋白质、维生素、氨基酸等,其中,水溶性多糖和黄酮是主要活性成分,具有镇静安神、补中益气、养心益肾的功效,还具有抗衰老、抗氧化、增强免疫等作用,可以用于治疗脾虚泄泻、带下量多、遗精滑精、遗尿尿频、心悸失眠、怔忡健忘等;
百合为百合科植物百合的干燥肉质鳞叶,百合具有养阴润肺,清心安神的功效,还有宁心安神的作用,同时有美容,防癌,提高免疫力,延缓衰老,健胃作用,而且有清热解毒、止咳、祛痰、平喘的作用;
黑豆为豆科植物大豆的干燥成熟种子,黑豆味甘,性平,归脾、肾经,具有益精明目、养血祛风、利水、解毒的功效,黑豆中含有花色苷、异黄酮等多酚类物质,并且黑豆中多酚类物质的含量高于其他豆类,黑豆能降血糖、降血脂、抗氧化、抗肿瘤、缓解疲劳、保护肝肾、抗凝血等,还具有类似激素样作用。黑豆可用于治疗阴虚烦渴、头晕目昏、体虚多汗、肾虚腰痛、水肿尿少、痹痛拘挛、手足麻木、药食中毒;
浮小麦为禾本科小麦属植物小麦的干燥轻浮瘪瘦的果实,味甘;性凉,心经,主止阴虚发热,盗汗,自汗,无论阳虚自汗或阴虚盗汗均可以应用;
灵芝为多孔菌科真菌赤芝或紫芝的干燥子实体,甘,平,归心、肺、肝、肾经,具有补气安神,健脑,消炎,利尿,益肾的功效,能止咳平喘,用于眩晕不眠,心悸气短,虚劳咳喘;
其中,黄花菜具有良好的改善睡眠的功效,为君药;酸枣仁、远志安神益智,帮助改善睡眠,为臣药;莲子、百合、黑豆养阴益精,为佐药;浮小麦、灵芝载药上行以使药力缓留于上部心经,为使药。远志,味苦、辛,性温,长期服用可能会造成燥热之症,百合,味甘,性寒,长期服用可能会造成寒凉之症,两药相互作用,制约对方的不良之性,从而达到相辅相成的效果;本申请的植物饮料为纯中药制剂,改善了辅助睡眠这类产品以西药占绝对市场的情况,相比西药,患者不会因为长期服用而产生依耐性;现今,黄花菜绝大部分是以初级农产品进行销售,本发明是以黄花菜为主要原料,制成一款时尚健康的植物饮品,提高了黄花菜产品的经济附加值,可以促进黄花菜的产业化进程、促进黄花菜产地的农民增收和新农村建设;本申请的植物饮料除有明确的改善睡眠功能外,还有美容养颜、抗氧防衰、养血平肝、宽胸解郁、消肿利尿、缓解更年期症状;本申请的植物饮料中的中药组分经水煮浸提后,各中药成分大都在浓缩液中,成分浸提效果好,食用后吸收利用率高,且制备成植物饮料,可直接规律性饮用,给失眠患者带来了福音。
优选的,按重量份数计,所述植物饮料包括以下组分:黄花菜12份,酸枣仁9份,远志6份,莲子9份,百合6份,黑豆3份,浮小麦10份,灵芝9份,辅料1.35份。
优选的,按重量份数计,所述辅料包括以下组分:甜味剂0.05-0.25份,酸度调节剂0.15-1份,食用香料0.25-1份。
更为优选的,按重量份数计,所述辅料包括以下组分:甜味剂0.15份,酸度调节剂0.55份,食用香料0.6份。
优选的,所述甜味剂包括甜菊糖苷,罗汉果甜苷,甘草甜素中的一种或多种。
优选的,所述酸度调节剂包括柠檬酸,苹果酸,柠檬酸钠中的一种或多种。
优选的,所述食用香料包括迷迭香提取物,薰衣草提取物,罗勒提取物中的一种或多种。
一种改善睡眠的植物饮料的制备方法,包括如下步骤:
步骤1,取上述黄花菜,酸枣仁,远志,莲子,百合,黑豆,浮小麦和灵芝混合,得混合物;
步骤2、将混合物用纯化水水煮提取,获得提取液;
步骤3、将提取液固液分离,获得澄清液;
步骤4、澄清液进行浓缩,获得浓缩液;
步骤5、向浓缩液中加入上述重量份的辅料,得植物饮料。
优选的,步骤2中将混合物用纯化水水煮两次,第一次加水量为混合物重量的8-18倍,第二次加水量为混合物重量的8-14倍,每次水煮提取1-3h。
优选的,步骤4中浓缩液浓缩至澄清液体积的1/3-1/2。
本申请中,黄花菜,酸枣仁,远志,莲子,百合,黑豆,浮小麦,灵芝均的产地均为道地产区。
综上所述,由于采用了上述技术方案,本发明的有益效果是:
1,本发明中,黄花菜具有良好的改善睡眠的功效,为君药;酸枣仁、远志安神益智,帮助改善睡眠,为臣药;莲子、百合、黑豆养阴益精,为佐药;浮小麦、灵芝载药上行以使药力缓留于上部心经,为使药;
2、本发明中,远志,味苦、辛,性温,长期服用可能会造成燥热之症;百合,味甘,性寒,长期服用可能会造成寒凉之症;两药相互作用,制约对方的不良之性,从而达到相辅相成的效果;
3、本申请的植物饮料为纯中药制剂,改善了辅助睡眠这类产品以西药占绝对市场的情况,相比西药,患者不会因为长期服用而产生依耐性;
4、现今,黄花菜绝大部分是以初级农产品进行销售,本发明是以黄花菜为主要原料,制成一款时尚健康的植物饮品,提高了黄花菜产品的经济附加值,可以促进黄花菜的产业化进程、促进黄花菜产地的农民增收和新农村建设;
5、本申请的植物饮料除有明确的改善睡眠功能外,还有美容养颜、抗氧防衰、养血平肝、宽胸解郁、消肿利尿、缓解更年期症状,还能增强和改善大脑功能,对注意力不集中,记忆力减退等有特殊疗效;
6、制备方法简单可靠,有效成分提取完全,可直接饮用;
7、成人食用50-100g鲜黄花菜后,其中含有0.1-0.2mg秋水仙碱,会出现急性中毒症状,表现为口渴、咽干、恶心、呕吐等,严重者会出现血便、血尿等,本申请通过两次水煮,使秋水仙碱变性,彻底解决黄花菜的不良反应,产品食用安全性高。
具体实施方式
为了使本发明的目的,技术方案及优点更加清楚明白,以下实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。
实施例1
一种改善睡眠的植物饮料,按重量份数计,包括黄花菜10份,酸枣仁5份,远志3份,莲子6份,百合6份,黑豆3份,浮小麦10份,灵芝6份,甜味剂0.05份,酸度调节剂0.15份,食用香料0.25份,甜味剂为甜菊糖苷,酸度调节剂为柠檬酸,食用香料为迷迭香提取物。
上述改善睡眠的植物饮料方法,包括如下步骤:
步骤1、取上述黄花菜,酸枣仁,远志,莲子,百合,黑豆,浮小麦,灵芝混合,得混合物;
步骤2、将混合物投入提取罐,注入混合物重量的10倍量的纯化水,煎煮1h,获得提取液1,再注入混合物重量的12倍量的纯化水,煎煮1.5h,获得提取液2;
步骤3、将提取液1和提取液2混合,用板框压滤机进行过滤,获得澄清液;
步骤4、将澄清液注入浓缩器中进行低温浓缩,获得浓缩液,浓缩液浓缩至澄清液体积的1/3;
步骤5、向浓缩液中加入上述重量份的甜菊糖苷、柠檬酸、迷迭香提取物进行矫味,获得植物饮料原液;
步骤6、植物饮料原液进行灌装、高温高压灭菌,即得。
实施例2
一种改善睡眠的植物饮料,按重量份数计,包括黄花菜12份,酸枣仁9份,远志6份,莲子9份,百合6份,黑豆3份,浮小麦10份,灵芝9份,甜味剂0.15份,酸度调节剂0.55份,食用香料0.6份,甜味剂为罗汉果甜苷,酸度调节剂为柠檬酸钠,食用香料为薰衣草提取物。
上述改善睡眠的植物饮料方法,包括如下步骤:
步骤1、取上述黄花菜,酸枣仁,远志,莲子,百合,黑豆,浮小麦,灵芝混合,得混合物;
步骤2、将混合物投入提取罐,注入混合物重量的13倍量的纯化水,煎煮1.5h,获得提取液1,再注入混合物重量的10倍量的纯化水,煎煮1h,获得提取液2;
步骤3、将提取液1和提取液2混合,用板框压滤机进行过滤,获得澄清液;
步骤4、将澄清液注入浓缩器中进行低温浓缩,获得浓缩液,浓缩液浓缩至澄清液体积的2/5;
步骤5、向浓缩液中加入上述重量份的罗汉果甜苷、柠檬酸钠、薰衣草提取物进行矫味,获得植物饮料原液;
步骤6、植物饮料原液进行超高温瞬时灭菌、灌装,即得。
实施例3
一种改善睡眠的植物饮料,按重量份数计,包括黄花菜18份,酸枣仁12份,远志10份,莲子12份,百合12份,黑豆6份,浮小麦15份,灵芝12份,甜味剂0.25份,酸度调节剂1份,食用香料1份,甜味剂为甘草甜素,酸度调节剂为苹果酸,食用香料为罗勒提取物。
上述改善睡眠的植物饮料方法,包括如下步骤:
步骤1、取上述黄花菜,酸枣仁,远志,莲子,百合,黑豆,浮小麦,灵芝混合,得混合物;
步骤2、将混合物投入提取罐,注入混合物重量的18倍量的纯化水,煎煮2h,获得提取液1,再注入混合物重量的14倍量的纯化水,煎煮2h,获得提取液2;
步骤3、将提取液1和提取液2混合,用板框压滤机进行过滤,获得澄清液;
步骤4、将澄清液注入浓缩器中进行低温浓缩,获得浓缩液,浓缩液浓缩至澄清液体积的1/2;
步骤5、向浓缩液中加入上述重量份的甘草甜素、苹果酸、罗勒提取物进行矫味,获得植物饮料原液;
步骤6、植物饮料原液进行灌装、高温高压灭菌,即得。
试验例
本申请植物饮料改善睡眠功能的试验
1)健康雌性ICR小鼠,清洁级,质量18-22g,各项试验所用动物按体质量分成4组,每组12只,设2.5、5、10mL·kg-1·d-1(选用实施例2制得的样品作为受试物,分别相当于成人每日每千克体质量推荐摄入量的5倍、10倍、20倍)3个样品剂量组和阴性对照组(双蒸水),以灌胃方式给予受试药物,连续给受试物30d。以动物的翻正反射消失超过30~60s判为进入睡眠,翻正反射恢复即为动物觉醒。如实验组入睡动物数及睡眠时间增加并与阴性对照组有显著差异,即判定该项实验结果为阳性。
2)延长戊巴比妥纳睡眠时间试验:各组动物均于末次灌胃15min后腹腔注射戊巴比妥纳55mg/kg,注射量为0.2mL/20g,以小鼠翻正反射消失为指标,观察受样品能否延长戊巴比妥纳睡眠时间。
3)巴比妥钠阈下剂量催眠实验:末次给药15min后,各组小鼠腹腔注射巴比妥钠130mg/kg,注射量为0.2mL/20g。以小鼠翻正反射消失60s以上为入睡标准,观察记录30min内各组小鼠入睡的只数,并计算入睡率。如给药组小鼠的入睡率增高且与对照组相比具有显著差异,即判定该项结果为阳性。
4)巴比妥钠睡眠潜伏期实验:各组动物均于末次灌胃15min后腹腔注射巴比妥纳205mg/kg,注射量为0.2mL/20g,以小鼠翻正反射消失为指标,记录各组动物睡眠潜伏期。如给药组小鼠的睡眠潜伏期缩短且与对照组相比具有显著差异,即判定该项结果为阳性。
5)试验结果:
5.1直接睡眠影响:实验组小鼠在给药后,部分小鼠出现安静、活动减少及嗜睡的状态,但均未出现睡眠现象,而空白对照组小鼠动物全部为清醒状态。说明该样品对小鼠无直接睡眠作用,本实验结果为阴性。
5.2对延长戊巴比妥钠睡眠时间的影响:见表1,与空白对照组相比,样品各剂量组小鼠睡眠时间均延长。经方差分析,该样品低剂量组小鼠的睡眠时间显著延长(P<0.05),而中、高剂量组小鼠的睡眠时间极显著延长(P<0.01)。说明该样品可延长戊巴比妥钠诱导的小鼠睡眠时间,实验结果为阳性。
组别 | 剂量(mL/kg·d) | 睡眠时间(min) | 延长率(%) |
空白对照组 | 0 | 40.2±5.3 | 0 |
低剂量组 | 2.5 | 55.4±6.6* | 37.8 |
中剂量组 | 5 | 67.8±7.5** | 68.7 |
高剂量组 | 10 | 69.3±7.2** | 72.4 |
注:与对照组比较,*表示P<0.05,**表示P<0.01
5.3对巴比妥钠阈下剂量催眠作用的影响:见表2,与空白对照组相比,样品各剂量组入睡小鼠个数随剂量增加而增多,中、高剂量组入睡小鼠只数与空白对照组相比有显著性差异,实验结果阳性。
组别 | 剂量(mL/kg·d) | 入睡只数(只) | 入睡率(%) |
空白对照组 | 0 | 3 | 25.0 |
低剂量组 | 2.5 | 4 | 33.3 |
中剂量组 | 5 | 8** | 66.7 |
高剂量组 | 10 | 10** | 83.3 |
注:与对照组比较,*表示P<0.05,**表示P<0.01
5.4对巴比妥钠睡眠潜伏期的影响:见表3,与空白对照组相比,各剂量小鼠睡眠潜伏期经方差分析,中、高剂量组有显著性差异(P<0.05),表明中、高剂量组样品均可缩短小鼠巴比妥钠睡眠潜伏期,实验结果阳性。
注:与对照组比较,*表示P<0.05,**表示P<0.01
6)研究结果表明:本申请的植物饮料对小鼠无直接睡眠作用,而巴比妥钠睡眠潜伏期、延长戊巴比妥钠睡眠时间和对巴比妥钠阈下剂量催眠作用的实验结果均为阳性。根据保健食品功能学评价标准,判定本申请的植物饮料具有一定的改善睡眠的功能。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改,等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种改善睡眠的植物饮料,其特征在于,按重量份数计,所述植物饮料包括以下组分:黄花菜10-18份,酸枣仁5-12份,远志3-10份,莲子6-12份,百合6-12份,黑豆3-6份,浮小麦10-15份,灵芝6-12份,辅料0.45-2.25份。
2.根据权利要求1所述的一种改善睡眠的植物饮料,其特征在于,按重量份数计,所述植物饮料包括以下组分:黄花菜12份,酸枣仁9份,远志6份,莲子9份,百合6份,黑豆3份,浮小麦10份,灵芝9份,辅料1.35份。
3.根据权利要求1或2所述的一种改善睡眠的植物饮料,其特征在于,按重量份数计,所述辅料包括以下组分:甜味剂0.05-0.25份,酸度调节剂0.15-1份,食用香料0.25-1份。
4.根据权利要求3所述的一种改善睡眠的植物饮料,其特征在于,按重量份数计,所述辅料包括以下组分:甜味剂0.15份,酸度调节剂0.55份,食用香料0.6份。
5.根据权利要求3或4所述的一种改善睡眠的植物饮料,其特征在于,所述甜味剂包括甜菊糖苷,罗汉果甜苷,甘草甜素中的一种或多种。
6.根据权利要求3或4所述的一种改善睡眠的植物饮料,其特征在于,所述酸度调节剂包括柠檬酸,苹果酸,柠檬酸钠中的一种或多种。
7.根据权利要求3或4所述的一种改善睡眠的植物饮料,其特征在于,所述食用香料包括迷迭香提取物,薰衣草提取物,罗勒提取物中的一种或多种。
8.一种如权利要求1-7任一项所述的改善睡眠的植物饮料的制备方法,其特征在于,包括如下步骤:
步骤1,取上述黄花菜,酸枣仁,远志,莲子,百合,黑豆,浮小麦和灵芝混合,得混合物;
步骤2、将混合物用纯化水水煮提取,获得提取液;
步骤3、将提取液固液分离,获得澄清液;
步骤4、澄清液进行浓缩,获得浓缩液;
步骤5、向浓缩液中加入上述重量份的辅料,得植物饮料。
9.根据权利要求8所述的一种改善睡眠的植物饮料的制备方法,其特征在于,步骤2中将混合物用纯化水水煮两次,第一次加水量为混合物重量的8-18倍,第二次加水量为混合物重量的8-14倍,每次水煮提取1-3h。
10.根据权利要求8所述的一种改善睡眠的植物饮料的制备方法,其特征在于,步骤4中浓缩液浓缩至澄清液体积的1/3-1/2。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011190446.7A CN112314819A (zh) | 2020-10-30 | 2020-10-30 | 一种改善睡眠的植物饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011190446.7A CN112314819A (zh) | 2020-10-30 | 2020-10-30 | 一种改善睡眠的植物饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112314819A true CN112314819A (zh) | 2021-02-05 |
Family
ID=74297410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011190446.7A Pending CN112314819A (zh) | 2020-10-30 | 2020-10-30 | 一种改善睡眠的植物饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112314819A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114190500A (zh) * | 2021-12-17 | 2022-03-18 | 山西振东五和医养堂股份有限公司 | 一种改善睡眠的植物饮料及其制备方法 |
CN115429860A (zh) * | 2022-05-23 | 2022-12-06 | 山东中医药大学 | 一种发酵养血安神饮及其制备工艺 |
CN116058503A (zh) * | 2022-12-31 | 2023-05-05 | 贵州斛妍堂生物科技有限公司 | 一种改善睡眠、缓解疲劳的黄精咀嚼片及其制备方法 |
CN117158522A (zh) * | 2023-08-29 | 2023-12-05 | 祁东云兴湖现代农业科技生态园发展有限公司 | 一种改善睡眠的黄花菜饮品及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104998098A (zh) * | 2015-06-24 | 2015-10-28 | 谢晓亮 | 一种改善睡眠的固体饮料及制备方法 |
CN105596702A (zh) * | 2016-01-07 | 2016-05-25 | 辽宁泰阳医药科技开发有限公司 | 一种具有改善睡眠功能的中药组合物 |
CN109549193A (zh) * | 2017-09-27 | 2019-04-02 | 东莞自然衡健康科技有限公司 | 一种中药复方改善睡眠的保健食品及其制备方法 |
-
2020
- 2020-10-30 CN CN202011190446.7A patent/CN112314819A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104998098A (zh) * | 2015-06-24 | 2015-10-28 | 谢晓亮 | 一种改善睡眠的固体饮料及制备方法 |
CN105596702A (zh) * | 2016-01-07 | 2016-05-25 | 辽宁泰阳医药科技开发有限公司 | 一种具有改善睡眠功能的中药组合物 |
CN109549193A (zh) * | 2017-09-27 | 2019-04-02 | 东莞自然衡健康科技有限公司 | 一种中药复方改善睡眠的保健食品及其制备方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114190500A (zh) * | 2021-12-17 | 2022-03-18 | 山西振东五和医养堂股份有限公司 | 一种改善睡眠的植物饮料及其制备方法 |
CN115429860A (zh) * | 2022-05-23 | 2022-12-06 | 山东中医药大学 | 一种发酵养血安神饮及其制备工艺 |
CN115429860B (zh) * | 2022-05-23 | 2023-08-04 | 山东中医药大学 | 一种发酵养血安神饮及其制备工艺 |
CN116058503A (zh) * | 2022-12-31 | 2023-05-05 | 贵州斛妍堂生物科技有限公司 | 一种改善睡眠、缓解疲劳的黄精咀嚼片及其制备方法 |
CN117158522A (zh) * | 2023-08-29 | 2023-12-05 | 祁东云兴湖现代农业科技生态园发展有限公司 | 一种改善睡眠的黄花菜饮品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112314819A (zh) | 一种改善睡眠的植物饮料及其制备方法 | |
CN107811249B (zh) | 一种红枣人参保健果冻的制备方法 | |
CN103689563A (zh) | 一种有助于改善睡眠的养生保健食品配方及其制备方法 | |
CN111956753B (zh) | 一种药食同源的中药组合物及其制备方法和应用 | |
CN113768004A (zh) | 一种含陈皮的白茶调味茶及其制备方法 | |
CN107737268A (zh) | 疏肝散结且祛斑养颜膏方及其制备方法 | |
CN110613134B (zh) | 具有降血糖功能的保健食品及其制备方法 | |
CN114190500A (zh) | 一种改善睡眠的植物饮料及其制备方法 | |
CN107048110A (zh) | 香圆天麻石仙桃固体饮料及其制备方法 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
CN104798950A (zh) | 免疫功夫茶及其制备方法 | |
CN111358922A (zh) | 温补肾阳改善寒性体质的中药组合物及其制备方法和应用 | |
TW202330006A (zh) | 氣虛及/或血虛相關症狀之預防、改善或緩和用之組合物 | |
CN110093239A (zh) | 一种诺丽配制酒及其制备方法 | |
CN108403933A (zh) | 一种月子餐下奶康复气血双补中药组合物及其制备方法 | |
CN103444933B (zh) | 一种夏季养身中午茶袋泡茶 | |
CN112293630A (zh) | 一种促进泌乳的植物饮料及其制备方法 | |
CN110692787A (zh) | 菊花六宝茶及其制备方法 | |
CN115737746B (zh) | 药食同源归脾汤改良物及其制备方法、药物和食品组合物 | |
CN117503833B (zh) | 一种食药两用的壮阳补肾中药组合物及其制备方法 | |
CN109170052A (zh) | 一种石斛养胃保健茶及其制备方法 | |
CN103750425A (zh) | 一种高丽红参罗汉果汤的制备方法 | |
CN113812498B (zh) | 一种植物基咖啡组合物及其制备方法与应用 | |
CN107582829A (zh) | 一种防癌抗癌的功能食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210205 |